Efficacy of Fluticasone propionate / Formoterol fumarate hydrate on human bronchial mucocillially movement using bronchoscopic specimen

Efficacy of Fluticasone propionate / Formoterol fumarate hydrate on human bronchial mucocillially movement using bronchoscopic specimen - Fluticasone / Formoterol on human bronchial mucocillially movement

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017645

Enrollment

Registered

2015-05-21

Start date

2015-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory disease requiring bronchoscopy

Interventions

administration of Fluticasone / Formoterol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Respiratory disease requiring bronchoscopy and bronchial lavage clinically

Exclusion criteria

Exclusion criteria: serious major organ dysfunction

Design outcomes

Primary

Measure	Time frame
Activity of the movement of cilia of epithelial cells, ciliary movement frequency, and ciliary movement amplitude before and after Fluticasone/fumarate load	—

Countries

Japan

Contacts

Public ContactToshiyujki Sawa

Gifu Municipal Hospital Cancer Center

sawatoshiyuki@yahoo.co.jp0081-58-251-1101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026